{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:45:11Z","timestamp":1784249111049,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004106","name":"East China Normal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004106","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274010"],"award-info":[{"award-number":["82274010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["18430760400"],"award-info":[{"award-number":["18430760400"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["RCJD2022S06"],"award-info":[{"award-number":["RCJD2022S06"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021524","name":"School of Life Sciences and Biotechnology Division of Life Sciences, Korea University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.toxlet.2024.04.010","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T02:17:42Z","timestamp":1713925062000},"page":"36-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Non-alcoholic fatty liver disease changes the expression and activity of hepatic drug-metabolizing enzymes and transporters in rats"],"prefix":"10.1016","volume":"396","author":[{"given":"Yifei","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenmeizi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junze","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2024.04.010_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010210","article-title":"Metabolomics and lipidomics screening reveal reprogrammed signaling pathways toward cancer development in non-alcoholic steatohepatitis","volume":"24","author":"Ahmed","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.toxlet.2024.04.010_bib2","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1007\/s10620-014-3289-x","article-title":"Expression of liver X receptor correlates with intrahepatic inflammation and fibrosis in patients with nonalcoholic fatty liver disease","volume":"59","author":"Ahn","year":"2014","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.toxlet.2024.04.010_bib3","article-title":"Transporter-mediated alterations in patients With NASH increase systemic and hepatic exposure to an OATP and MRP2 substrate","author":"Ali","year":"2017","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.toxlet.2024.04.010_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27030858","article-title":"A comparison of the gene expression profiles of non-alcoholic fatty liver disease between animal models of a high-fat diet and methionine-choline-deficient diet","volume":"27","author":"Alshawsh","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.toxlet.2024.04.010_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cmet.2013.04.021","article-title":"Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance","volume":"18","author":"Beaven","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.toxlet.2024.04.010_bib6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0006-291X(03)00811-8","article-title":"Vitamin E and drug metabolism","volume":"305","author":"Brigelius-Flohe","year":"2003","journal-title":"Biochem Biophys. Res. Commun."},{"key":"10.1016\/j.toxlet.2024.04.010_bib7","doi-asserted-by":"crossref","first-page":"18528","DOI":"10.1074\/jbc.M109.099333","article-title":"Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione","volume":"285","author":"Caballero","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2024.04.010_bib8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2024.04.010_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108391","article-title":"PPAR-\u03b3 signaling in nonalcoholic fatty liver disease: pathogenesis and therapeutic targets","volume":"245","author":"Chen","year":"2023","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.toxlet.2024.04.010_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.toxlet.2018.07.021","article-title":"Design and optimization of the cocktail assay for rapid assessment of the activity of UGT enzymes in human and rat liver microsomes","volume":"295","author":"Chen","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2024.04.010_bib11","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/hep.30652","article-title":"Fructose promotes leaky gut, endotoxemia, and liver fibrosis through ethanol-inducible cytochrome P450-2E1-mediated oxidative and nitrative stress","volume":"73","author":"Cho","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2024.04.010_bib12","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1124\/dmd.106.009670","article-title":"Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts","volume":"34","author":"Donato","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2024.04.010_bib13","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1124\/dmd.109.027466","article-title":"Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease","volume":"37","author":"Fisher","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2024.04.010_bib14","article-title":"Recent advances in understanding microbial regulation of host multi-drug resistance transporters","volume":"23","author":"Foley","year":"2021","journal-title":"Curr. Opin. Physiol."},{"key":"10.1016\/j.toxlet.2024.04.010_bib15","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/hepr.12282","article-title":"Abnormality of autophagic function and cathepsin expression in the liver from patients with non-alcoholic fatty liver disease","volume":"44","author":"Fukuo","year":"2014","journal-title":"Hepatol. Res"},{"key":"10.1016\/j.toxlet.2024.04.010_bib16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1124\/mol.117.111047","article-title":"Effects of Farnesoid X receptor activation on arachidonic acid metabolism, NF-kB signaling, and hepatic inflammation","volume":"94","author":"Gai","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.toxlet.2024.04.010_bib17","doi-asserted-by":"crossref","first-page":"G1281","DOI":"10.1152\/ajpgi.00074.2008","article-title":"Gene expression in human NAFLD","volume":"294","author":"Greco","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.toxlet.2024.04.010_bib18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1124\/dmd.112.048439","article-title":"Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease","volume":"41","author":"Hardwick","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2024.04.010_bib19","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1016\/j.xphs.2019.08.021","article-title":"CYP1A2 downregulation by obeticholic acid: usefulness as a positive control for the in vitro evaluation of drug-drug interactions","volume":"108","author":"Ishida","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.toxlet.2024.04.010_bib20","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1021\/acs.molpharmaceut.8b00159","article-title":"Nonalcoholic fatty liver disease and diabetes are associated with decreased CYP3A4 protein expression and activity in human liver","volume":"15","author":"Jamwal","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.toxlet.2024.04.010_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.freeradbiomed.2022.08.037","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2\/NQO-1 pathway","volume":"192","author":"Kang","year":"2022","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.toxlet.2024.04.010_bib22","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.toxlet.2024.04.010_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154170","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease","author":"Mantovani","year":"2020","journal-title":"Metab. 111S"},{"key":"10.1016\/j.toxlet.2024.04.010_bib24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/liv.13031","article-title":"The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment","volume":"36","author":"Margini","year":"2016","journal-title":"Liver Int."},{"key":"10.1016\/j.toxlet.2024.04.010_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7861\/clinmedicine.18-3-245","article-title":"Non-alcoholic fatty liver disease","volume":"18","author":"Maurice","year":"2018","journal-title":"Clin. Med. (Lond.)"},{"key":"10.1016\/j.toxlet.2024.04.010_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/03602532.2011.577781","article-title":"Drug metabolism alterations in nonalcoholic fatty liver disease","volume":"43","author":"Merrell","year":"2011","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.toxlet.2024.04.010_bib27","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/iub.1991","article-title":"Role of vitamin E in nonalcoholic fatty liver disease","volume":"71","author":"Nagashimada","year":"2019","journal-title":"IUBMB Life"},{"key":"10.1016\/j.toxlet.2024.04.010_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12916-017-0806-8","article-title":"Non-alcoholic fatty liver disease","volume":"15","author":"Neuschwander-Tetri","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.toxlet.2024.04.010_bib29","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/CM9.0000000000002092","article-title":"Hepatocyte nuclear factor 4alpha in the pathogenesis of non-alcoholic fatty liver disease","volume":"135","author":"Pan","year":"2022","journal-title":"Chin. Med J. (Engl. )"},{"key":"10.1016\/j.toxlet.2024.04.010_bib30","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MCG.0b013e31824587e0","article-title":"Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease","volume":"46","author":"Polyzos","year":"2012","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.toxlet.2024.04.010_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bcp.2017.07.013","article-title":"Cytochrome P450 3A selectively affects the pharmacokinetic interaction between erlotinib and docetaxel in rats","volume":"143","author":"Qin","year":"2017","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.toxlet.2024.04.010_bib32","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","volume":"26","author":"Raza","year":"2021","journal-title":"Front Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.toxlet.2024.04.010_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/574832","article-title":"Nonalcoholic steatohepatitis: a search for factual animal models","volume":"2015","author":"Sanches","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.toxlet.2024.04.010_bib34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/hep.32542","article-title":"NAFLD-related hepatocellular carcinoma: the growing challenge","volume":"77","author":"Shah","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2024.04.010_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FPC.0b013e328333a1dd","article-title":"The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease","volume":"20","author":"Sookoian","year":"2010","journal-title":"Pharm. Genom."},{"key":"10.1016\/j.toxlet.2024.04.010_bib36","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s11695-010-0078-2","article-title":"Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease","volume":"20","author":"Stepanova","year":"2010","journal-title":"Obes. Surg."},{"key":"10.1016\/j.toxlet.2024.04.010_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fitote.2013.10.004","article-title":"Inhibitory effects of celastrol on rat liver cytochrome P450 1A2, 2C11, 2D6, 2E1 and 3A2 activity","volume":"92","author":"Sun","year":"2014","journal-title":"Fitoterapia"},{"key":"10.1016\/j.toxlet.2024.04.010_bib38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.25630","article-title":"Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis","volume":"56","author":"Tanaka","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2024.04.010_bib39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.toxlet.2017.09.014","article-title":"Assessment of the inhibition risk of shikonin on cytochrome P450 via cocktail inhibition assay","volume":"281","author":"Tang","year":"2017","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2024.04.010_bib40","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1124\/mol.116.104687","article-title":"A Fibroblast Growth Factor 21-Pregnane X receptor pathway downregulates hepatic CYP3A4 in Nonalcoholic Fatty Liver Disease","volume":"90","author":"Woolsey","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.toxlet.2024.04.010_bib41","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1124\/dmd.115.065979","article-title":"CYP3A activity and expression in nonalcoholic fatty liver disease","volume":"43","author":"Woolsey","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2024.04.010_bib42","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1038\/ncomms8466","article-title":"A metabolic stress-inducible miR-34a-HNF4\u03b1 pathway regulates lipid and lipoprotein metabolism","volume":"6","author":"Xu","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxlet.2024.04.010_bib43","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cmet.2010.04.005","article-title":"Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance","volume":"11","author":"Yang","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.toxlet.2024.04.010_bib44","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12072-010-9202-6","article-title":"Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease","volume":"4","author":"Yang","year":"2010","journal-title":"Hepatol. Int"},{"key":"10.1016\/j.toxlet.2024.04.010_bib45","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1872-034X.2008.00399.x","article-title":"Gene expression profiling of non-alcoholic steatohepatitis using gene set enrichment analysis","volume":"38","author":"Yoneda","year":"2008","journal-title":"Hepatol. Res"},{"key":"10.1016\/j.toxlet.2024.04.010_bib46","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2024.04.010_bib47","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.toxlet.2024.04.010_bib48","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cbi.2019.05.038","article-title":"CYP3A suppression during diet-induced nonalcoholic fatty liver disease is independent of PXR regulation","volume":"308","author":"Zeng","year":"2019","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.toxlet.2024.04.010_bib49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3892\/etm.2015.2846","article-title":"Effects of a combination of puerarin, baicalin and berberine on the expression of proliferator-activated receptor-gamma and insulin receptor in a rat model of nonalcoholic fatty liver disease","volume":"11","author":"Zhao","year":"2016","journal-title":"Exp. Ther. Med"},{"key":"10.1016\/j.toxlet.2024.04.010_bib50","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/138920009787522151","article-title":"Role of NF-kappaB in the regulation of cytochrome P450 enzymes","volume":"10","author":"Zordoky","year":"2009","journal-title":"Curr. Drug Metab."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037842742400081X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037842742400081X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:27:16Z","timestamp":1778750836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037842742400081X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":50,"alternative-id":["S037842742400081X"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2024.04.010","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-alcoholic fatty liver disease changes the expression and activity of hepatic drug-metabolizing enzymes and transporters in rats","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2024.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}